Articles

1. Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations

   • Yu-Cheng Chang
   • Hui-Jen Tsai
   • Sung-Hsin Kuo

   Original Article 27 April 2024

   

2. Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura

   • Olga Mulas
   • Fabio Efficace
   • Giovanni Caocci

   Research Open access 27 April 2024

   

3. GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy

   • Yanfeng Liu
   • Yi Liu
   • Xiaoping Chen

   Research 27 April 2024

   

4. Enhancing end-of-life care: ethical considerations and the role of social work in geriatric bone marrow biopsy decisions

   • Shijie Guo
   • Guang Yang

   Correspondence 25 April 2024

5. Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice

   • Aleksander Chojecki
   • Danielle Boselli
   • Michael Richard Grunwald

   Research Open access 25 April 2024

6. Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study

   • Hui Shi
   • Fan Yang
   • Kai Hu

   Research 25 April 2024

   

7. Dermatologic manifestations of hematologic disorders

   • Hannah L. King
   • Genevieve B. Benedetti
   • Kylee L. Martens

   Review 25 April 2024

   

8. Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia

   • Kumiyo Tazoe
   • Naonori Harada
   • Hirohisa Nakamae

   Original Article 25 April 2024

   

9. Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco

   • Sara Benchikh
   • Soro Somda Georgina Charlène
   • Sanaa Nassereddine

   Original Article 24 April 2024

   

10. Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series

    • Mengze Hu
    • Junhui Li
    • Litian Xuan

    Research 24 April 2024

    

11. Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis

    • Marko Lucijanic
    • Ivan Krecak
    • Rajko Kusec

    Correspondence 23 April 2024

    

12. Letter to Editor: Treatment with the apoptosis inhibitor asunercept reduces clone sizes in patients with lower risk myelodysplastic neoplasms

    • Syeda Dua e Zehra Zaidi
    • Syeda Mahrukh Fatima Zaidi
    • Burhanuddin Sohail Rangwala

    Correspondence 23 April 2024

13. Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis

    • Chih-Cheng Chen
    • Justin L. Chen
    • Hsin-An Hou

    Research Open access 23 April 2024

    

14. SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports

    • Ryohei Ono
    • Izumi Kitagawa

    Review 23 April 2024

    

15. Bortezomib elevates intracellular free Fe²⁺ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells

    • Yanyan Zhang
    • Fen He
    • Jiliang Xia

    Research 22 April 2024

    

16. Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia

    • Shanshan Qin
    • Yingxin Jiang
    • Yunfeng Cheng

    Original Article 22 April 2024

    

17. Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG)

    • Huayuan Zhu
    • Xiao Lu
    • Wenyu Shi

    Research 22 April 2024

    

18. Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel

    • Julie Kanter
    • Kenneth I. Ataga
    • Michael S. Broder

    Original Article 20 April 2024

    

19. Diagnosing aceruloplasminemia: navigating through red herrings

    • Zeni Kharel
    • Himal Kharel
    • Pradyumna D. Phatak

    Case Report 19 April 2024

20. Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCT

    • Lingxia Cai
    • Diange Jin
    • Yishan Ye

    Research 19 April 2024

    

21. COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study

    • Sophie Thau
    • Christian Bjørn Poulsen
    • Lars Møller Pedersen

    Research Open access 18 April 2024

    

22. Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML

    • Akriti G Jain
    • Quinto Gesiotto
    • Kendra Sweet

    Research Open access 18 April 2024

    

23. Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial

    • Aishwarya Anand
    • Naveen C Hegde
    • Samir Malhotra

    Research 18 April 2024

    

24. Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies

    • Lourdes Cordón
    • Pedro Chorão
    • Jaime Sanz

    Research 18 April 2024

    

25. Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report

    • Gurjeet Bhangu
    • Kelsey Uminski
    • Natalia Rydz

    Letter to the Editor 17 April 2024

    

26. Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey

    • Andrea Duminuco
    • Alessandra Romano
    • Carlo Visco

    Research 17 April 2024

    

27. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia

    • Daniel Zechariah Paul Jebanesan
    • Raveen Stephen Stallon Illangeswaran
    • Poonkuzhali Balasubramanian

    Original Article 17 April 2024

    

28. Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines

    • Charalampos Charalampous
    • Darshi Shah
    • Rajshekhar Chakraborty

    Review 17 April 2024

29. A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs

    • Fuxin Ma
    • Zhiwei Zeng
    • Jinhua Zhang

    Research 17 April 2024

    

30. Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes

    • Zhuxin Zhang
    • Qinglin Hu
    • Bing Han

    Original Article 15 April 2024

    

31. Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture

    • Katsuyoshi Shimozawa
    • Hiroshi Yagasaki
    • Ichiro Morioka

    Correspondence 13 April 2024

    

32. Post-transplant lymphoproliferative disease of two different histological types

    • Takashi Onaka
    • Koichi Ohshima
    • Akihito Yonezawa

    Dear Editor, 13 April 2024

    

33. Therapeutic progress in relapsed/refractory multiple myeloma

    • Qi Chen
    • Min Zhang
    • Yamin Tan

    Review Article 13 April 2024

34. Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study

    • Salvatore Leotta
    • Uros Markovic
    • Giuseppe Milone

    Research 13 April 2024

    

35. Loss of NLRP6 expression increases the severity of intestinal injury after syngeneic hematopoietic stem cell transplantation

    • Shengyun Zhu
    • Xue Zhang
    • Kailin Xu

    Research 12 April 2024

    

36. Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study

    • Zhenyang Gu
    • Fei Li
    • Daihong Liu

    Original Article 12 April 2024

    

37. Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients

    • Bo Kyung Kim
    • Kyung Taek Hong
    • Hyoung Jin Kang

    Original Article Open access 10 April 2024

    

38. Could it be VEXAS?

    • Hippolyte Guerineau
    • Milena Kohn
    • Aurélie Cabannes-Hamy

    Case Report 09 April 2024

    

39. Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century

    • Zhengjiu Cui
    • Fei Luo
    • Yueli Pan

    Review 09 April 2024

    

40. Thiotepa-busulfan-fludarabine-based conditioning as a promising approach prior to allogeneic hematopoietic stem cell transplantation in patients with blastic plasmacytoid dendritic cell neoplasm

    • Xianbo Huang
    • Shasha Wang
    • Jiejing Qian

    Case Report 08 April 2024

    

41. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China

    • Lan Luo
    • Yang Jiao
    • Hongmei Jing

    Research 06 April 2024

    

42. Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia

    • Antonella Meloni
    • Laura Pistoia
    • Filippo Cademartiri

    Original Article 06 April 2024

43. Quality of life after immune suppressive therapy in aplastic anemia

    • Iris N. Lommerse
    • Chris Hinnen
    • Jennifer M.-L. Tjon

    Original Article Open access 05 April 2024

    

44. Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma

    • Takumi Kondo
    • Keito Ohara
    • Kensuke Kojima

    Letter to the Editor 03 April 2024

    

45. Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study

    • Lucía Pérez-Lamas
    • Raquel de Paz Arias
    • Valentín García-Gutiérrez

    Research 03 April 2024

    

46. Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report

    • Jiawen Wang
    • Han Zhu
    • Kourong Miao

    Case Report 01 April 2024 Pages: 1775 - 1777

47. The role of therapeutic plasma exchange in plasma cell disorders

    • Danai Dima
    • Jack Khouri

    Review Open access 01 April 2024

    

48. Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians

    • Cordula Gebel
    • Isabel Kruschel
    • Ulrich Wedding

    Research Open access 28 March 2024 Pages: 1753 - 1763

    

49. Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation

    • Zhengqin Tian
    • Qihang Man
    • Jingbo Wang

    Research 28 March 2024 Pages: 1729 - 1736

    

50. Correction to: Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia

    • Yue Chen
    • Mengge Pan
    • Peipei Xu

    Correction 27 March 2024 Pages: 1801 - 1801